Free Newsletter
J&J hands Congress 20K pages of Tylenol documentation
J&J continues to hand over to Congress some 20,000 pages of documentation concerning the Tylenol and other children's medication recalls that originated at its GMP-violation-riddled Pennsylvania plant. The page count exceeds 20,000, with more to come. The documents are stacked in the House Oversight and Government Reform Committee in-box, on top of more than 1,000 pages collected from the of FDA. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: